EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieKohortenstudie

Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study

John C Hardman iD, James Constable iD, Sian Dobbs iD, Christopher Hogan iD, Kate Hulse iD, Shivun Khosla iD, Kristijonas Milinis iD, Ben Tudor-Green iD, Andrew Williamson iD, Vinidh Paleri iD, INTEGRATE (The UK ENT Trainee Research Network)

Clinical Otolaryngology · 2024

DOI: 10.1111/coa.14167 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Otolaryngology, 2024. Verfasst von John C Hardman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Head and Neck Unit, The Royal Marsden Hospital, London, UK. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: ENT UK Foundation Research Grants Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To investigate factors influencing survival in head and neck squamous cell carcinoma of unknown primary (HNSCCUP).

Methods

A retrospective observational cohort study was conducted, over 5 years from January 2015, in UK Head and Neck centres, of consecutive adults undergoing 18F‐Fluorodeoxyglucose‐PET‐CT within 3 months of diagnosis with metastatic cervical squamous cell carcinoma. Patients treated as HNSCCUP underwent survival analysis, stratified by neck dissection and/or radiotherapy to the ipsilateral neck, and by HPV status.

Results

Data were received from 57 centres for 965 patients, of whom 482 started treatment for HNSCCUP (65.7% HPV‐positive, n = 282/429). Five‐year overall survival (OS) for HPV‐positive patients was 85.0% (95% CI 78.4–92.3) and 43.5% (95% CI 32.9–57.5) for HPV‐negative. HPV‐negative status was associated with worse OS, disease‐free (DFS), and disease‐specific (DSS) survival (all p < .0001 on log‐rank test) but not local control (LC) ( p = .16). Unilateral HPV‐positive disease treated with surgery alone was associated with significantly worse DFS ( p < .0001) and LC ( p < .0001) compared to radiotherapy alone or combined modalities (5‐year DFS: 24.9%, 82.3% and 94.3%; 5‐year LC: 41.8%, 98.8% and 98.6%). OS was not significantly different ( p = .16). Unilateral HPV‐negative disease treated with surgery alone was associated with significantly worse LC ( p = .017) (5‐year LC: estimate unavailable, 93.3% and 96.6%, respectively). Small numbers with bilateral disease precluded meaningful sub‐group analysis.

Conclusions

HPV status is associated with variable management and outcomes in HNSCCUP. Unilateral neck disease is treated variably and associated with poorer outcomes when managed with surgery alone. The impact of diagnostic oropharyngeal surgery on primary site emergence, survival and functional outcomes is unestablished.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimarySquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsPositron Emission Tomography Computed TomographyHumansFemaleRetrospective StudiesMaleMiddle AgedAgedUnited KingdomSurvival RateAdultAged, 80 and overNeck Dissection

Stichwörter der Autor:innen

human papillomavirusneck dissectionneoplasm metastasissquamous cell carcinoma of head and neckunknown primary neoplasms

Autor:innen und Institutionen

  • Head and Neck Unit, The Royal Marsden Hospital, London, UK.
  • Department of Otolaryngology, Head and Neck Surgery, Gloucestershire Royal Hospital, Gloucester, UK.
  • Manchester Royal Infirmary, Manchester Foundation Trust, Manchester, UK.
  • Department of Otolaryngology, Head and Neck Surgery, Basildon University Hospital, Basildon, UK.
  • Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Department of Otolaryngology, Head and Neck Surgery, Royal Surrey County Hospital, Guildford, UK.

ORCID-Profile: John C Hardman, James Constable, Sian Dobbs, Christopher Hogan, Kate Hulse, Shivun Khosla, Kristijonas Milinis, Ben Tudor-Green, Andrew Williamson, Vinidh Paleri

Förderung

  • ENT UK Foundation Research Grants Programme

Zitieren

APA

Hardman, J. C., Constable, J., Dobbs, S., Hogan, C., Hulse, K., Khosla, S., Milinis, K., Tudor-Green, B., Williamson, A., Paleri, V., & INTEGRATE (The UK ENT Trainee Research Network) (2024). Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study. Clinical Otolaryngology. https://doi.org/10.1111/coa.14167

Vancouver

Hardman JC, Constable J, Dobbs S, Hogan C, Hulse K, Khosla S, et al. Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study. Clinical Otolaryngology. 2024. doi:10.1111/coa.14167

BibTeX
@article{Hardman2024,
  author = {Hardman, John C and Constable, James and Dobbs, Sian and Hogan, Christopher and Hulse, Kate and Khosla, Shivun and Milinis, Kristijonas and Tudor-Green, Ben and Williamson, Andrew and Paleri, Vinidh and INTEGRATE (The UK ENT Trainee Research Network), INTEGRATE (The UK ENT Trainee Research Network)},
  title = {Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study},
  journal = {Clinical Otolaryngology},
  year = {2024},
  doi = {10.1111/coa.14167}
}
Kostenlos starten →